Genetic testing for lung cancer

The necessity for genetic testing: High-throughput detection of multiple genes can analyze different mutation types of multiple genes at one time. It will analyze targeted-, chemo-therapy simultaneously, provides comprehensive instructions of personalized remedy for lung cancer patients and maximize the beneficial possibility for patients.

Detection method: The comprehensive coverage of lung cancer associated early stage driver genes, drug sensitive genes and drug resistant genes is carried out via the second generation of high-throughput sequencing techniques. Then precisely analyze the corresponding targeted medicine specific to known oncogenic driver genes. Finally, realize the possibility of different treatments for the same cancer, and provide comprehensive reference information for clinical professionals to facilitate the choice of personalized therapeutic plans.